|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25892-25898, September 3, 1999
From the Division of Clinical Nutrition, National Institute of
Health and Nutrition,
1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8636, Japan
Dietary fish oil induces hepatic
peroxisomal and microsomal fatty acid oxidation by peroxisome
proliferator-activator receptor Dietary fish oil contains n-3 fatty acids, such as
eicosapentaenoic acid and docosahexaenoic acid, which decrease blood
triglyceride concentrations in hypertriglycemic patients and are
considered to have protective effects against cardiovascular diseases
(1). This effect of n-3 fatty acids mainly results from the
combined effects of inhibition of lipogenesis and stimulation of fatty acid oxidation in liver (2, 3). It has been shown that n-3 fatty acids in vivo or in cell culture inhibited the
transcription of genes coding for lipogenesis enzymes, such as fatty
acid synthase (FAS),1
acetyl-CoA carboxylase (ACC), stearoyl-CoA desaturase (SCD), and S14
protein (4, 5). On the other hand, n-3 fatty acids increased
the transcription of the regulatory enzymes of fatty acid oxidation,
such as lipoprotein lipase (LPL), fatty acid-binding protein, acyl-CoA
synthetase (ACS), carnitine palmitoyltransferase 1, acyl-CoA
dehydrogenese, and acyl-CoA oxidase (4, 5).
The molecular mechanisms by which n-3 fatty acids regulate
gene transcription have not yet been clarified, but on the basis of
in vitro assays and in comparison with peroxisome
proliferators, such as fibrate compounds, it has been suggested that
n-3 fatty acids can regulate gene transcription through the
activation of a transcription factor, peroxisome proliferator-activated
receptor (PPAR) On the other hand, sterol regulatory element-binding proteins (SREBPs)
are other important transcription factors that regulate fatty acid and
cholesterol metabolism in liver (11). In sterol depletion, SREBPs are
cleaved and become mature forms to bind sterol regulatory elements
(SREs) (12, 13) and/or E-box sequences (14) and then activate the
target gene expression. Thus, both expression levels and processing of
SREBPs regulate the target gene expression. Furthermore, three forms of
SREBPs, SREBP-1a, SREBP-1c, and SREBP-2, are expressed in liver, and
they use different promoters for their own expression (15, 16). In
addition, studies on transgenic mice that over-expressed SREBP-1a (17), SERBP-1c (18), and SREBP-2 (19) in liver demonstrated that they have
different potencies for regulation of target gene expression. The
target genes of SREBPs involved in cholesterol metabolism include LDL
receptor, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, HMG-CoA
synthase, and SREBP itself (17-19). Genes involved in fatty acid and
triglyceride synthesis that are regulated by SREBPs include ACC, FAS,
and SCD-1 (17-19).
We examined SREBP mRNAs and their protein levels in liver from fish
oil-fed mice. Our experiment demonstrated that in liver, fish oil
feeding decreased SREBP-1c gene expression and resulted in decrease of
mature SREBP-1 protein. These data provide a new mechanism for
down-regulation of mRNAs of cholesterologenic and lipogenic enzymes
observed in fish oil feeding.
Fish Oil Diet Experiment--
Female C57BL/6J mice were obtained
from Tokyo Laboratory Animals Science Co. (Tokyo, Japan) at 7 weeks of
age and fed a normal laboratory diet (CE2, Clea, Tokyo, Japan) for 1 week to stabilize the metabolic conditions. Mice were exposed to a 12-h
light/12-h dark cycle and maintained at a constant temperature of
22 °C. Mice were divided into three groups (n = 13-16 in each group). Each group was divided into three cages, with
each cage containing 4-6 mice. The first group was given a high
carbohydrate diet that, on a calorie basis, contained 63%
carbohydrate, 11% fat, and 26% protein. In the high carbohydrate
diet, safflower oil was used as source of fat. The second group was
given a safflower oil-rich diet containing 14% carbohydrate, 60%
safflower oil, and 26% protein. The third group was given a high fish
oil diet containing 14% carbohydrate, 60% fish oil (mainly from
tuna), and 26% protein. Fatty acid compositions of dietary oils were
measured by gas-liquid chromatography. Safflower oil (high oleic type)
contained 46% oleic acid (18:1n-9) and 45% linoleic acid
(18:2n-6) from total fatty acids; fish oil contained 7%
eicosapentaenoic acid (20:5n-3) and 24% docosahexaenoic
acid (22:6n-3). The materials and methods of diet
preparation and those of estimation of energy intake were the same as
those used in our previous studies (20, 21). Mice were fed each diet
for 5 months. At the end of the experiments, animals were anesthetized
at about 10:00 a.m. by intraperitoneal injection of pentobarbital
sodium (0.08 mg/g of body weight; Nembutal, Abbot, North Chicago, IL).
Liver was isolated immediately, weighed, and homogenized in
guanidine-thiocyanate, and RNA was prepared by the method described by
Chirgwin et al. (22). A part of liver of each mouse was
immediately homogenized to obtain membrane fractions and nuclear
extracts (23), and the other portion of liver was frozen for
measurement of triglyceride and cholesterol as described in previously
(24).
Fibrate Administration--
Female C57BL/6J mice
(n = 5; 7 weeks of age) were treated for 2 weeks with
fenofibrate (Sigma) mixed in high carbohydrate diet that had the same
ingredient used in fish oil diet study. Control mice (n = 5) were fed under the same conditions but in the absence of
fenofibrate. Because each mouse consumed approximately 1.5-2.0 g of
chow/day, doses of 0.5% (w/w) mixed in diet correspond to 410-550
mg/kg of body weight/day. Mice were fed each diet for 2 weeks. Mice
were sacrificed in a method similar to that of the fish oil diet experiment.
Preparation of cDNA Probe for Northern Blot--
The
cDNA fragments for mouse SREBP-1, SREBP-2, HMG-CoA reductase,
HMG-CoA synthase, apoE, and LPL were obtained by polymerase chain
reaction from first strand cDNA using mouse liver total RNA. Total
RNA from mouse liver was isolated by the method of Chirgwin et
al. (22). First strand cDNA was prepared using a Superscript
II kit (Life Technologies, Inc.) primed with oligo-dT. The polymerase
chain reaction primers used were as follows (17, 31): SREBP-1,
5' primer, 5'-TCAACAACCAAGACAGTGACTTCCCTGGCC-3', and 3' primer,
5'-GTTCTCCTGCTTGAGCTTCTGGTTGCTGTG-3'; SREBP-2, 5' primer,
5'-CATGGACACCCTCACGGAGCTGGGCGACGA-3', and 3' primer, 5'-TGCATCATCCAATAGAGGGCTTCCTGGCTC-3'; HMG-CoA reductase, 5' primer, 5'-GGGACGGTGACACTTACCATCTGTATGATG-3', and 3' primer,
5'-ATCATCTTGGAGAGATAAAACTGCCA-3'; HMG-CoA synthase, 5' primer,
5'-TATGATGGTGTAGATGCTGGGAAGTATACC-3', and 3' primer,
5'-TAAGTTCTTCTGTGCTTTTCATCCAC-3'; apoE, 5' primer, 5'-TGGGAGCAGGCCCTGAACCGCTTC-3', and 3' primer,
5'-GAGTCGGGCCTGTGCCGCCTGCAC-3'; and LPL, 5' primer,
5'-GTGGCCGCAGCAGACGCAGGAAGA-3', and 3' primer, 5'-CATCCAGTTGATGAATCTGGCCAC-3'. Polymerase chain reaction was performed
with a Tag DNA polymerase (Takara, Shiga, Japan). Thirty-two cycles of amplification were made by using the following program: 94 °C, 40 s; 68 °C, 1 min; and 72 °C, 2 min. The
amplified products were subcloned into pGEM-T Easy vector (Promega,
Madison, WI). The cDNA probes for rat LDL receptor and rat ACS were
kindly provided by Dr. T. Yamamoto at Tohoku University (25, 26), mouse
SCD-1 was provided by Dr. Daniel M. Lane at Johns Hopkins University (27), and rat ACC and rat FAS were provided by Dr. N. Iritani at
Tezukayama Gakuin College (28, 29). These cDNAs were used as probes
for Northern blotting.
Northern Blotting--
Aliquots of total RNA(10-15 µg) were
denatured with glyoxal and dimethyl sulfoxide, subjected to
electrophoresis in a 1% agarose gel, and transferred to nylon
membranes (NEN Life Science Products). After transfer and UV
cross-linking, RNA blots were stained with methylene blue to locate 28 S and 18 S rRNAs and to ascertain the amount of loaded RNAs (30). The
membranes were hybridized with each cDNA probe labeled with
[ RNase Protection Assay--
The cDNA fragment specific to
either mouse SREBP-1a or SREBP-1c was amplified by polymerase chain
reaction from first strand cDNA prepared using mouse liver total
RNA. The following primers were used. SREBP-1a: 5' primer,
5'-TAGTCCGAAGCCGGGTGGGCGCCGGCGCCAT-3'; 3' primer,
5'-GATGTCGTTCAAAACCGCTGTGTGTCCAGTTC-3' (Table I from Ref. 31).
SREBP-1c: 5' primer, 5'-ATCGGCGCGGAAGCTGTCGGGGTAGCGTC-3'; 3' primer,
5'-ACTGTCTTGGTTGTTGATGAGCTGGAGCAT-3' (31). The amplified products
were subcloned into pGEM-T Easy vector (Promega, Madison, WI). After
linearization of plasmid, antisense RNA was transcribed with
[ Immunoblotting--
Pooled liver membranes and nuclear extracts
from 5-6 mice of each group were prepared by the method described by
Sheng et al. (23). The same amount of protein from each
fraction was applied to 7% SDS-polyacrylamide gel electrophoresis and
transferred to Hybond-P membranes (Amersham Pharmacia Biotech).
Immunoblot analysis was performed by using the ECL Western blotting
detection system kit (Amersham Pharmacia Biotech). Membrane sheets were first incubated with antibody against SREBP-1 or SREBP-2 for 1 h
at 22 °C and then washed several times and incubated with
horseradish peroxidase-conjugated anti-mouse IgG according to the
protocol supplied by the manufacturer. The bands were quantified by
scanning with Canon IX-4015 (Canon Inc., Tokyo, Japan). Monoclonal
antibodies to SREBP-1 (IgG-2A4) and SREBP-2 (IgG-7D4) were purified by
protein A-Sepharose (Amersham Pharmacia Biotech) from the supernatant of hybridoma cell lines CRL 2121 and CRL 2198, respectively. These cell
lines were purchased from American Tissue Culture Collection (Manassas, VA).
Other Analyses--
Blood samples were obtained by cutting the
tail end under feeding conditions. Triglyceride concentrations were
measured by enzyme assays, determiner LTG (Kyowa Medics, Tokyo, Japan)
and cholesterol by determiner LTC (Kyowa Medics).
Statistical Analysis--
Comparisons of data from multiple
groups were made by one-way analysis of variance. When they were
significant, each group was compared with the others by Fisher's
protected least significant difference test (Statview 4.0, Abacus
Concepts). Comparisons of data from two experimental groups were made
by unpaired Student's t test. Statistical significance is
defined as p < 0.05. Values are mean ± S.E.
The phenotypic comparison of mice fed three different diets for 5 months is summarized in Table I. In
agreement with our previous data (20, 21, 24), compared with high
carbohydrate-fed mice, safflower oil-fed mice showed a 1.4-fold
increase in body weight (p < 0.001), a 3.5-fold
increase of parametrial white adipose tissue weight (p < 0.001), and a 1.5-fold increase of triglyceride accumulation in
liver (p < 0.001). In contrast, fish oil-fed mice did
not develop obesity or triglyceride accumulation in liver. However, the
average energy intake among these three groups was not significantly
different (7.4 ± 0.5, 7.7 ± 0.9, and 8.0 ± 0.5 kcal/mouse/day in carbohydrate, safflower oil, and fish oil-fed mice,
respectively; n = 5). Fish oil feeding also affected
lipid metabolism. Liver cholesterol and triglyceride concentrations from fish oil-fed mice were lower by 35% (p < 0.05)
and 62% (p < 0.001), respectively, than those from
safflower oil-fed mice. Plasma cholesterol and triglycerides
concentrations from fish oil-fed mice were also lower by 32%
(p < 0.001) and 36% (p = 0.19), respectively, than those from safflower oil-fed mice. Liver weight from
fish oil-fed mice was 25% greater than that from safflower oil-fed
mice (p < 0.001). This might be due to the well known effects of fish oil on peroxisomal proliferation (32).
Fig. 1 shows immunoblots of the precursor
and mature SREBP-1 and -2 in liver of mice fed high carbohydrate, high
safflower oil, and high fish oil diets for 5 months. Because antibody
to SREBP-1 reacted to both SREBP-1a and -1c forms, we could not
distinguish these two forms, and we used the noncommittal term SREBP-1.
However, in mouse liver, the ratio of SREBP-1c to -1a transcripts is
9:1 (31), and thus the -1c form accounted for most of SREBP-1 observed on the immunoblots. In preliminary experiments, to confirm that 125- and 68-kDa proteins we observed are really the precursor and mature
SREBP-1, fasting and refeeding experiments were conducted. Both
precursor and mature SREBP-1 were decreased by 48 h fasting and
increased above nonfasted levels by refeeding (data not shown). This
confirms not only previous finding (33) but also confirms that the
bands at which we aimed were SREBP-1. There were no differences in the
amount of SREBP-1 and -2 in both precursor and mature forms between
carbohydrate- and safflower oil-fed mice. However, compared with
safflower oil feeding, fish oil feeding reduced the amount of precursor
SREBP-1 in membrane fraction by 90% and that of mature SREBP-1 in
liver nuclei by 57% (Fig. 1A). Fish oil feeding also reduced the precursor SREBP-2 by 65% but did not alter the amount of
mature SREBP-2 (Fig. 1B). In this experiment and others (23, 33), SREBP bands often appeared as closely spaced doublets, but the
reason is not clear.
Fish Oil Feeding Decreases Mature Sterol Regulatory
Element-binding Protein 1 (SREBP-1) by Down-regulation of SREBP-1c
mRNA in Mouse Liver
A POSSIBLE MECHANISM FOR DOWN-REGULATION OF LIPOGENIC ENZYME
mRNAs*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
activation, whereas it
down-regulates lipogenic gene expression by unknown mechanism(s).
Because sterol regulatory element-binding proteins (SREBPs)
up-regulated lipogenic genes, investigation was made on the effects of
fish oil feeding on SREBPs and sterol regulatory element
(SRE)-dependent gene expression in C57BL/6J mice. Three
forms of SREBPs, SREBP-1a, -1c, and -2, are expressed in liver, and
their truncated mature forms activate transcription of sterol-regulated
genes. C57BL/6J mice were divided into three groups; the first group
was given a high carbohydrate diet, and the other two groups were given
a high fat diet (60% of total energy), with the fat in the form of
safflower oil or fish oil, for 5 months. Compared with safflower oil
feeding, fish oil feeding decreased triglyceride and cholesterol
concentrations in liver. There were no differences in amount of SREBP-1
and -2 in both precursor and mature forms between carbohydrate- and
safflower oil-fed mice. However, compared with safflower oil feeding,
fish oil feeding reduced the amounts of precursor SREBP-1 in membrane fraction by 90% and of mature SREBP-1 in liver nuclei by 57%. Fish
oil feeding also reduced precursor SREBP-2 by 65% but did not alter
the amount of mature SREBP-2. Compared with safflower oil feeding, fish
oil feeding decreased liver SREBP-1c mRNA level by 86% but did not
alter SERBP-1a mRNA. Consistent with decrease of mature SREBP-1,
compared with safflower oil feeding, fish oil feeding down-regulated
the expression of liver SRE-dependent genes, such as low
density lipoprotein receptor, 3-hydroxy-3-methylglutaryl-CoA reductase,
3-hydroxy-3-methylglutaryl-CoA synthase, fatty acid synthase,
acetyl-CoA carboxylase, and stearoyl-CoA desaturase-1. These data
suggested that in liver, fish oil feeding down-regulates the mature
form of SREBP-1 by decreasing SREBP-1c mRNA expression, with
corresponding decreases of mRNAs of cholesterologenic and lipogenic enzymes.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(6-9). In addition, a recent study to examine fish
oil feeding on several genes expression in PPAR knockout mice clearly indicated that hepatic gene regulation of fish oil feeding involved at
least two distinct pathways, a PPAR
-dependent and a
PPAR
-independent pathway (10). Interestingly, enzymes for
peroxisomal (cytochrome P450 4A2) and microsomal (acyl-CoA oxidase)
oxidation are PPAR
-dependent and are up-regulated,
whereas enzymes for lipid synthesis (FAS and S14) are
PPAR
-independent and are downregulated (10).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]dCTP (NEN Life Science Products) by a random
primer labeling kit (Amersham Pharmacia Biotech). The membranes were
hybridized overnight at 42 °C in hybridization buffer, subsequently
washed one time with 1× SSC, 0.1% SDS at 22 °C, two times for 30 min at 50 °C, and one time for 30 min at 65 °C. The membranes
were exposed to Kodak XAR-5 film at
80 °C with intensifying
screens. Quantitative analysis was performed with an image analyzer
(BAS 2000, Fuji Film, Tokyo, Japan) and expressed as the intensity of
phosphostimulated luminescence.
-32P]CTP (800 Ci/mmol) using bacteriophage T7 or SP6
RNA polymerase (Promega). Specific activities of the transcribed RNAs
were measured in each experiment and were in the range of 0.8-1.2 × 109 cpm/µg. Aliquots of total RNA(10 µg) from mouse
liver were subjected to RNase protection assay using a RPA
IITM kit (Ambion, Inc., Austin, TX). After digestion with
RNase A/T1, protected fragments were separated on 8 M
urea/4.8% polyacylamide gels. The gels were dried and then subjected
to autoradiography. Quantitative analysis was performed with an image
analyzer (BAS 2000).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Phenotypic comparison of high carbohydrate-, high safflower oil-, and
high fish oil-fed mice

View larger version (43K):
[in a new window]
Fig. 1.
Immunoblot analysis of SREBP-1
(A) and SREBP-2 (B) in membrane
fractions and nuclear extracts from livers of mice fed high
carbohydrate, high safflower oil, and high fish oil diets. Mice
were killed at 5 months of feeding. For each group, livers from mice
(n = 5-6) were pooled, and 80-µg aliquots of
membrane fractions and nuclear extracts were subjected to 7%
SDS-polyacrylamide gel electrophoresis and electrophoretically
transferred to Hybond-P membranes. The membrane fractions and nuclear
extracts were incubated with 5 µg/ml of mouse monoclonal antibody IgG
2A4 against amino acids 301-407 of human SREBP-1 or IgG 7D4 against
amino acid 32-250 of hamster SREBP-2. Immunoblot analysis was carried
out by the enhanced chemiluminescence system. Filters were exposed to
film for 60 s for SREBP-1 or 90 s for SREBP-2. The bands were
quantified by scanning with Canon IX-4015 (Canon Inc., Tokyo, Japan).
P and M denote the precursor and mature forms of
SREBPs, respectively. In A, a typical autoradiogram of
SREBP-1 from membrane fractions and nuclear extracts and its relative
levels are shown. In B, a typical autoradiogram of SREBP-2
from membrane fractions and nuclear extracts and its relative levels
are shown. Two independent experiments were conducted. As both
experiments showed similar results, one of the experiments is shown
here.
To examine whether a marked decrease of SREBP-1 protein and a moderate
decrease of SREBP-2 protein level by fish oil feeding reflected their
mRNA levels, SREBP-1 and -2 mRNA levels in liver were measured
by Northern blotting (Fig. 2). Parallel
to their protein levels, compared with safflower oil-fed mice, fish
oil-fed mice showed markedly decreased SREBP-1 mRNA level by 80%
(p < 0.001). As for SREBP-2 mRNA, parallel to the
amount of its precursor form, it also decreased by 47% in fish oil-fed
mice (p < 0.001).
|
The SREBP-1 gene uses two different promoters to produce two different
transcripts, -1a and -1c, that differ in the first exon (15, 31). To
determine whether fish oil feeding reduces the amount of one or both
transcripts, an RNase protection experiment was conducted (Fig.
3). Compared with safflower oil feeding,
fish oil feeding reduced the amount of SREBP-1c transcript by 86%
(p < 0.001) but did not alter significantly the amount
of SREBP-1a transcript. Decrease of SREBP-1c mRNA by fish oil
feeding was observed in early stages of fish oil feeding, and we
observed 68% decrease of SREBP-1c mRNA only after 2 days of fish
oil feeding (data not shown). As noted previously (31) and also
observed in this study, in normal mice, the SREBP-1c transcript in the liver was more abundant than the SREBP-1a transcript. Thus, the SREBP-1c mRNA isoform may account for decrease of total SREBP-1 mRNA by fish oil feeding. Compared with carbohydrate feeding, safflower oil feeding reduced SERBP-1c mRNA by 39%
(p < 0.001), whereas there was no alteration of total
SREBP-1 mRNA levels between carbohydrate and safflower oil feeding
(Fig. 2A). These data indicate that there may be another
isoform of SREBP-1c that is up-regulated by safflower oil feeding.
|
The results of Northern blots of various mRNAs involved in
cholesterol and fatty acid metabolism in liver from three dietary groups are presented in Fig. 4 and Table
II. We examined mRNA levels involved
in cholesterologenic enzymes (LDL receptor, HMG-CoA reductase, and
HMG-CoA synthase), in lipogenic enzymes (FAS, ACC, and SCD-1) and, as a
negative control, mRNA level of apoE. Compared with
carbohydrate-fed mice, safflower oil-fed mice showed increases of
HMG-CoA reductase and HMG-CoA synthase mRNA by 43%
(p < 0.05) and 102% (p < 0.05),
respectively, and showed decreases of FAS and SCD-1 by 47%
(p < 0.01) and 67% (p < 0.001),
respectively. Compared with safflower oil-fed mice, fish oil-fed mice
showed marked decreases of LDL receptor, HMG-CoA reductase, HMG-CoA
synthase, FAS, and SCD-1 mRNA by 60% (p < 0.001),
80% (p < 0.001), 64% (p < 0.01),
83% (p < 0.01), and 85% (p < 0.01),
respectively, and presented a moderate decrease of ACC mRNA by 42%
(p < 0.01). Relative to carbohydrate-fed mice, the
mRNA for HMG-CoA synthase from fish oil-fed mice was only slightly
affected. It has been reported that fatty acids induced HMG-CoA
synthase gene expression by PPAR
activation (34). Indeed, in this
study, compared with carbohydrate feeding, safflower oil-fed mice
showed a 2-fold increase in HMG-CoA synthase mRNA level. Thus, in
fish oil-fed mice, up-regulation of HMG-CoA synthase mRNA by
PPAR
activation may interfere with its down-regulation by SREBP-1
protein decrease. ApoE mRNA level did not differ among these three
groups. Thus, corresponding with the decrease of SREBP-1 mature form,
mRNA levels of cholesterologenic and lipogenic enzymes were
down-regulated in fish oil feeding, relative to safflower oil feeding.
It should be noted that safflower oil feeding itself decreased FAS and
SCD-1 mRNA significantly. Indeed, repression of FAS and SCD-1
mRNA expression by safflower oil feeding has also been reported
(35, 36). These data indicated that the amount of mature SREBP-1
protein was not involved in safflower oil feeding-induced
down-regulation of FAS and SCD-1 gene expression.
|
|
To examine whether down-regulation of mRNAs of SREBP-1 and
SRE-related enzymes by fish oil feeding was due to activation of PPAR
by fish oil, the effects of a well known PPAR
activator, fenofibrate, on expression of mRNAs for SREBP1, lipogenic enzymes, and PPAR
-activated enzymes were investigated (Table
III). Two weeks of administration of
0.5% (w/w) fenofibrate increased LPL and ACS mRNAs expression by
5.4-fold (p < 0.001) and 2.3-fold (p < 0.001), respectively. LPL and ACS are well known enzymes, the
expression of which was increased by PPAR
activator (37, 38).
Although not shown here, fish oil feeding also up-regulated mRNAs
of LPL and ACS by 3.3-fold (n = 4, p < 0.001) and 3.1-fold (n = 4, p < 0.001), respectively. However, fenofibrate administration did not
decrease SREBP-1, FAS, and ACC mRNAs, but rather up-regulated ACC
mRNA by 2-fold (p < 0.01). Thus, unlike fish oil
feeding, fibrate administration did not affect SREBP-1 expression or
its related gene expression.
|
| |
DISCUSSION |
|---|
|
|
|---|
The major finding of this study is that high fish oil feeding reduces the amount of mature, active SREBP-1 protein in nuclear extracts. This reduction was explained by a marked reduction of SREBP-1c mRNA in liver and resulted in repression of SRE-related gene expression.
Similar profiles of SREBPs were observed in other metabolic conditions. Fasting for 24 h decreased SREBP-1c mRNA expression by 60% but not SREBP-1a mRNA (33). Parallel to SREBP-1c mRNA expression, decreases of similar levels in both precursor and mature forms of SREBP-1 protein were observed in fasting mice. Although both fish oil feeding and fasting down-regulated SREBP-1c transcript, ratios of the precursor and mature forms were different. Fish oil feeding decreased the precursor SREBP-1 by 90% but its mature form by 57%. In addition, fish oil feeding also reduced the precursor SREBP-2 by 65% but did not alter the amount of mature SREBP-2. This may be explained by a reduction in the rate of mature SREBPs degradation. However, a more plausible explanation is that the differences may be due to an increase in the conversion rate of precursor SREBPs to mature SREBPs. This increase may be due to a 32% decrease of total cholesterol in fish oil-fed mice (Table I). There was no difference of the amount of total cholesterol in liver under fasting conditions (33). A decrease in cholesterol may facilitate the conversion of precursor SREBPs to mature SREBPs and may then lead to increase in their mature forms (11). Unfortunately, however, as free cholesterol pool responsible for regulating SREBPs conversion has not been identified, it cannot be concluded that the decrease in total cholesterol level is responsible for conversion of precursor to mature forms. A decrease of total cholesterol content in liver in docosahexaenoic acid-fed rats has also been reported (39, 40). Fish oil diet-induced decreased activity of HMG-CoA reductase, a rate-limiting enzyme of cholesterol synthesis, is considered a cause of decrease of cholesterol content in liver (41, 42). Thus, it is possible that decrease of mature SREBP-1 leads to decrease HMG-CoA reductase mRNA, and then the amount of total cholesterol in liver is decreased. Increased conversion of precursor to mature SREBPs may be a adaptive mechanism against a marked reduction of SREBP-1c mRNA.
Studies of several lines of transgenic mouse (SREBP-1a (17), -1c (18), and -2 (19)) and of knockout mice (SREBP-1 (43)) could distinguish the role of each transcript. The liver normally produces predominately 1c isoform of SREBP-1 (31), which is a very weak activator of transcription of cholesterologenic enzymes (18), whereas SREBP-1a is the most active form of SREBP-1 (17) and SREBP-2 is a relatively selective activator of cholesterol synthesis, as opposed to fatty acid synthesis. Also, SREBP-1c is important in maintaining the basal level of transcription of FAS, ACC, and SCD-1, because mice homozygous for disrupted SREBP-1 allele had decreased basal hepatic mRNA levels of FAS, ACC, and SCD-1 but not those of cholesterologenic enzymes (43). As fish oil feeding has resulted in a marked reduction of SREBP-1c mRNA, we anticipated decreases of lipogenic enzymes but not cholesterologenic enzymes. However, fish oil feeding decreased mRNAs for both cholesterologenic and lipogenic enzymes (Table II). The reason for this discrepancy may be explained as follows. SREBP-1c has functions of maintaining not only basal lipogenic enzymes but also cholesterologenic enzymes. However, in SREBP-1 knockout mice, reduction of cholesterologenic enzymes was not detected because of induction of SREBP-2 (43). Another explanation is that because fish oil feeding decreased SREBP-2 mRNA under some conditions such that conversion of precursor form of SREBP-2 to mature form is not accelerated, functional mature form of SREBP-2 might decrease.
Recently, the effects of polyunsaturated fatty acids on SREBPs and expression of SRE-containing reporter gene in several cell lines have been reported (44). Unsaturated fatty acids treatment for 24 h caused significant down-regulation of SRE-containing reporter gene expression, and inhibition increased with fatty acid length and number of double bonds. Down-regulation of reporter gene expression was mediated by decrease of mature SREBP protein (44). Because there was no substantial decrease of precursor SREBPs, they suggested that the decrease of mature SREBPs was due to increase of intracellular regulatory pools of cholesterol but not to SREBPs mRNA levels. Thus, although polyunsaturated fatty acids decreased SRE-related gene expression both in cell lines and mice liver, their mechanisms are different. The reason for this discrepancy is not clear. It is possible that there may be metabolic differences between in vivo and in vitro studies. Indeed, SREBP-1c is predominant in most tissues, whereas SREBP-1a is predominant in most cell lines (31).
This study may provide an explanation for the mechanism of fish oil
diet-induced down-regulation of lipogenic enzymes (4, 5). It has also
been reported that fish oil diet decreased LDL receptor activity in rat
(45), its mRNA level in rabbit (46), and HMG-CoA reductase
activities in rat (42) and rabbit (41). Thus, it also may provide an
explanation for fish oil diet-induced down-regulation of
cholesterologenic enzymes under some conditions. It is clear from
PPAR
knockout mice that down-regulation of lipogenic enzymes by fish
oil feeding was not mediated through PPAR
activation (10). In
support of this, we observed that administration of fenofibrate (a
PPAR
ligand) for 2 weeks failed to down-regulate mRNAs of
SREBP-1 and lipogenic enzymes (Table III). Thus, down-regulation of
SREBP-1c by fish oil feeding was not mediated by activation of PPAR
.
The data presented here suggest that hypolipidemic effect of fish oil
feeding is produced by PPAR
activation and SREBP-1c mRNA
down-regulation in liver, and they are independent (Fig.
5). To verify this hypothesis, further
studies, including SREBP-1c promoter analysis and search for a cell
line that would mimic in vivo conditions, are required.
|
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Hitoshi Shimano at Tokyo University for advice in preparation of liver nuclear extract. We are also grateful to Dr. Daniel M Lane for supply of mouse SCD-1 cDNA, to Dr. N. Iritani for supply of rat FAS and rat ACC cDNAs, and to Dr. T. Yamamoto for supply of rat LDL receptor and rat ACS cDNAs.
| |
FOOTNOTES |
|---|
* This work was supported in part by Special Coordination Funds for Promoting Science and Technology from the Japanese Science and Technology Agency (Tokyo), research grants from the Japanese Ministry of Health and Welfare (Tokyo), and the Japanese Ministry of Education, Science, Sports and Culture (Tokyo).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-3-3203-5725;
Fax: 81-3-3207-3520; E-mail: ezaki@nih.go.jp.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: FAS, fatty acid synthase; PPAR, peroxisome proliferator-activated receptor; SRE, sterol regulatory element; SREBP, sterol regulatory element-binding protein; LDL, low density lipoprotein; HMG-CoA, 3-hydroxy-3-methylglutaryl-CoA; LPL, lipoprotein lipase; ACS, acyl-CoA synthetase; ACC, acetyl-Co A carboxylase; SCD, stearoyl-CoA desaturase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Nestel, P. J. (1990) Annu. Rev. Nutr. 10, 149-167[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Rustan, A. C., Nossen, J. O., Christiansen, E. N., and Drevon, C. A. (1988) J. Lipid Res. 29, 1417-1426[Abstract] |
| 3. | Halminski, M. A., Marsh, J. B., and Harrison, E. H. (1991) J. Nutr. 121, 1554-1561 |
| 4. | Clarke, S. D., and Jump, D. B. (1994) Annu. Rev. Nutr. 14, 83-98[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Pegorier, J.-P. (1998) Curr. Opin. Clin. Nutr. Metab. Care 1, 329-334 [CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Reddy, J. K., and Mannaerts, G. P. (1994) Annu. Rev. Nutr. 14, 343-370[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Schoonjans, K., Staels, B., and Auwerx, J. (1996) Biochim. Biophys. Acta 1302, 93-109[Medline] [Order article via Infotrieve] |
| 8. |
Krey, G.,
Braissant, O.,
L'Horset, F.,
Kalkhoven, E.,
Perroud, M.,
Parker, M. G.,
and Wahli, W.
(1997)
Mol. Endocrinol.
11,
779-791 |
| 9. | Latruffe, N., and Vamecq, J. (1997) Biochimie 79, 81-94[Medline] [Order article via Infotrieve] |
| 10. |
Ren, B.,
Thelen, A. P.,
Peters, J. M.,
Gonzalez, F. J.,
and Jump, D. B.
(1997)
J. Biol. Chem.
272,
26827-26832 |
| 11. | Sakai, J., Duncan, E. A., Rawson, R. B., Hua, X., Brown, M. S., and Goldstein, J. L. (1996) Cell 85, 1037-1046[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Briggs, M. R.,
Yokoyama, C.,
Wang, X.,
Brown, M. S.,
and Goldstein, J. L.
(1993)
J. Biol. Chem.
268,
14490-14496 |
| 13. |
Wang, X.,
Briggs, M. R.,
Hua, X.,
Yokoyama, C.,
Goldstein, J. L.,
and Brown, M. S.
(1993)
J. Biol. Chem.
268,
14497-14504 |
| 14. | Kim, J. B., Spotts, G. D., Halvorsen, Y. D., Shih, H. M., Ellenberger, T., Towle, H. C., and Spiegelman, B. M. (1995) Mol. Cell. Biol. 15, 2582-2588[Abstract] |
| 15. | Hua, X., Wu, J., Goldstein, J. L., Brown, M. S., and Hobbs, H. H. (1995) Genomics 25, 667-673[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Miserez, A. R., Cao, G., Probst, L. C., and Hobbs, H. H. (1997) Genomics 40, 31-40[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., and Goldstein, J. L. (1996) J. Clin. Invest. 98, 1575-1584[Medline] [Order article via Infotrieve] |
| 18. | Shimano, H., Horton, J. D., Shimomura, I., Hammer, R. E., Brown, M. S., and Goldstein, J. L. (1997) J. Clin. Invest. 99, 846-854[Medline] [Order article via Infotrieve] |
| 19. | Horton, J. D., Shimomura, I., Brown, M. S., Hammer, R. E., Goldstein, J. L., and Shimano, H. (1998) J. Clin. Invest. 101, 2331-2339[Medline] [Order article via Infotrieve] |
| 20. | Ikemoto, S., Takahashi, M., Tsunoda, N., Maruyama, K., Itakura, H., and Ezaki, O. (1996) Metabolism 45, 1539-1546[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Tsunoda, N., Ikemoto, S., Takahashi, M., Maruyama, K., Itakura, H., Watanabe, H., Goto, N., and Ezaki, O. (1998) Metabolism 47, 724-730[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979) Biochemistry 18, 5294-5299[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Sheng, Z.,
Otani, H.,
Brown, M. S.,
and Goldstein, J. L.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
935-938 |
| 24. |
Ikemoto, S.,
Takahashi, M.,
Tsunoda, N.,
Maruyama, K.,
Itakura, H.,
Kawanaka, K.,
Tabata, I.,
Higuchi, M.,
Tange, T.,
Yamamoto, T.,
and Ezaki, O.
(1997)
Am. J. Physiol.
273,
E37-E45 |
| 25. |
Kim, D.,
Iijima, H.,
Goto, K.,
Sakai, J.,
Ishii, H.,
Kim, H.,
Suzuki, H.,
Kondo, H.,
Saeki, S.,
and Yamamoto, T.
(1996)
J. Biol. Chem.
271,
8373-8380 |
| 26. |
Suzuki, H.,
Kawarabayasi, Y.,
Kondo, J.,
Abe, T.,
Nishikawa, K.,
Kimura, S.,
Hashimoto, T.,
and Yamamoto, T.
(1990)
J. Biol. Chem.
265,
8681-8685 |
| 27. |
Ntambi, J. M.,
Buhrow, S. A.,
Kaestner, K. H.,
Christry, R. J.,
Sibley, E.,
Kelly, T. J., Jr.,
and Lane, M. D.
(1988)
J. Biol. Chem.
263,
17291-17300 |
| 28. | Katsurada, A., Iritani, N., Fukuda, H., Matsumura, Y., Nishimoto, N., Noguchi, T., and Tanaka, T. (1990) Eur. J. Biochem. 190, 427-433[Medline] [Order article via Infotrieve] |
| 29. | Katsurada, A., Iritani, N., Fukuda, H., Matsumura, Y., Nishimoto, N., Noguchi, T., and Tanaka, T. (1990) Eur. J. Biochem. 190, 435-441[Medline] [Order article via Infotrieve] |
| 30. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , pp. 187-206, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 31. | Shimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L., and Brown, M. S. (1997) J. Clin. Invest. 99, 838-845[Medline] [Order article via Infotrieve] |
| 32. | Reddy, J. K., and Chu, R. (1996) Ann. N. Y. Acad. Sci. 804, 176-201[Medline] [Order article via Infotrieve] |
| 33. |
Horton, J. D.,
Bashmakov, Y.,
Shimomura, I.,
and Shimano, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5987-5992 |
| 34. |
Rodríguez, J. C.,
Gil-Gómez, G.,
Hegardt, F. G.,
and Haro, D.
(1994)
J. Biol. Chem.
269,
18767-18772 |
| 35. | Clarke, S. D., Armstrong, M. K., and Jump, D. B. (1990) J. Nutr. 120, 225-231 |
| 36. | Landschulz, K. T., Jump, D. B., MacDougald, O. A., and Lane, M. D. (1994) Biochem. Biophys. Res. Commun. 200, 763-768[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., and Auwerx, J. (1996) EMBO J. 15, 5336-5348[Medline] [Order article via Infotrieve] |
| 38. |
Schoonjans, K.,
Watanabe, M.,
Suzuki, H.,
Mahfoudi, A.,
Krey, G.,
Wahli, W.,
Grimaldi, P.,
Staels, B.,
Yamamoto, T.,
and Auwerx, J.
(1995)
J. Biol. Chem.
270,
19269-19276 |
| 39. | Yamada, N., Shimizu, J., Wada, M., Takita, T., and Innami, S. (1998) J. Nutr. Sci. Vitaminol. 44, 279-289 |
| 40. | Ikeda, I., Wakamatsu, K., Inayoshi, A., Imaizumi, K., Sugano, M., and Yazawa, K. (1994) J. Nutr. 124, 1898-1906 |
| 41. | Field, F. J., Albright, E. J., and Mathur, S. N. (1987) J. Lipid Res. 28, 50-58[Abstract] |
| 42. | Froyland, L., Vaagenes, H., Asiedu, D. K., Garras, A., Lie, O., and Berge, R. K. (1996) Lipids 31, 169-178[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Shimano, H., Shimomura, I., Hammer, R. E., Herz, J., Goldstein, J. L., Brown, M. S., and Horton, J. D. (1997) J. Clin. Invest. 100, 2115-2124[Medline] [Order article via Infotrieve] |
| 44. |
Worgall, T. S.,
Sturley, S. L.,
Seo, T.,
Osborne, T. F.,
and Deckelbaum, R. J.
(1998)
J. Biol. Chem.
273,
25537-25540 |
| 45. | Roach, P. D., Kambouris, A. M., Trimble, R. P., Topping, D. L., and Nestel, P. J. (1987) FEBS Lett. 222, 159-162[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Wilkinson, J.,
Higgins, J. A.,
Fitzsimmons, C.,
and Bowyer, D. E.
(1998)
Arterioscler. Thromb. Vasc. Biol.
18,
1490-1497 |
This article has been cited by other articles:
![]() |
N. Tsuboyama-Kasaoka, K. Sano, C. Shozawa, T. Osaka, and O. Ezaki Studies of UCP2 transgenic and knockout mice reveal that liver UCP2 is not essential for the antiobesity effects of fish oil Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E600 - E606. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mori, H. Kondo, T. Hase, I. Tokimitsu, and T. Murase Dietary Fish Oil Upregulates Intestinal Lipid Metabolism and Reduces Body Weight Gain in C57BL/6J Mice J. Nutr., December 1, 2007; 137(12): 2629 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Kim, M. Della-Fera, J. Lin, and C. A. Baile Docosahexaenoic Acid Inhibits Adipocyte Differentiation and Induces Apoptosis in 3T3-L1 Preadipocytes J. Nutr., December 1, 2006; 136(12): 2965 - 2969. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Man, M. Miyazaki, K. Chu, and J. M. Ntambi Membrane Topology of Mouse Stearoyl-CoA Desaturase 1 J. Biol. Chem., January 13, 2006; 281(2): 1251 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Kapadia and F. V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids PNAS, February 15, 2005; 102(7): 2561 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ide Interaction of Fish Oil and Conjugated Linoleic Acid in Affecting Hepatic Activity of Lipogenic Enzymes and Gene Expression in Liver and Adipose Tissue Diabetes, February 1, 2005; 54(2): 412 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Benatti, G. Peluso, R. Nicolai, and M. Calvani Polyunsaturated Fatty Acids: Biochemical, Nutritional and Epigenetic Properties J. Am. Coll. Nutr., August 1, 2004; 23(4): 281 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Commerford, L. Peng, J. J. Dube, and R. M. O'Doherty In vivo regulation of SREBP-1c in skeletal muscle: effects of nutritional status, glucose, insulin, and leptin Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R218 - R227. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Worgall, S. R. Davis-Hayman, M. M. Magana, P. M. Oelkers, F. Zapata, R. A. Juliano, T. F. Osborne, T. E. Nash, and R. J. Deckelbaum Sterol and fatty acid regulatory pathways in a Giardia lamblia-derived promoter: evidence for SREBP as an ancient transcription factor J. Lipid Res., May 1, 2004; 45(5): 981 - 988. |